Acessibilidade / Reportar erro
Anais Brasileiros de Dermatologia, Volume: 97, Número: 5, Publicado: 2022
  • Genital ulcers caused by sexually transmitted agents, Continuing Medical Education

    Cunha Ramos, Mauro; Nicola, Maria Rita Castilhos; Bezerra, Natália Tenório Cavalcante; Sardinha, José Carlos Gomes; Morais, Julia Sampaio de Souza; Schettini, Antônio Pedro

    Resumo em Inglês:

    Abstract Genital ulcers (GUs) represent a diagnostic challenge and can be secondary to neoplastic and inflammatory processes of different causes. Among those of infectious etiology, there are sexually transmitted infections (STIs), a very frequent reason for seeking the health service. The most common agents are herpes simplex virus and Treponema pallidum and, more rarely, Haemophilus ducreyi, Klebsiella granulomatis and Chlamydia trachomatis. A careful dermatological examination offers important diagnostic elements; however, atypical manifestations are very common. Distinctive characteristics of ulcers to look out for include their margin, edge, bottom, and base. Regional lymph node chain alterations should be evaluated regarding their number, size, mobility, consistency, inflammation, and pain on palpation. Diagnostic tests have variable sensitivity and specificity, and molecular tests are currently considered the reference exams. The rapid immunochromatographic tests represented a significant advance, as they can be performed with blood obtained from the digital pulp, offer results in up to 30 minutes, and do not require a laboratory structure. The treatment of persons affected by GU/STIs must be immediate, as it aims to prevent complications, as well as reduce transmission. It is not always considered that people with GUs/STIs have varying degrees of depression, anxiety, and self-reproach, with an impact on relationships. Establishing a bond and trusting the professional is essential for adherence to treatment and preventive measures that must be discussed individually.
  • Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: real-world data from a retrospective multicenter study Original Article

    Topal, Ilteris Oguz; Baysak, Sevim; Altunay, İlknur Kıvanç; Polat, Asude Kara; Arıkan, Eylem Emel; Özkur, Ezgi; Aytekin, Sema; Dogan, Bilal; Akbulut, Tuǧba Özkök; Demir, Filiz Topaloǧlu; Karadaǧ, Ayșe Serap

    Resumo em Inglês:

    Abstract Background: Clinical studies have demonstrated that IL-17A inhibition with secukinumab is effective for clearing the skin of patients with psoriasis and has a favorable safety profile. Objective: The authors aim to determine whether secukinumab is effective and safe for the treatment of moderate-to-severe chronic psoriasis based on clinical experience with this drug. Method: The authors conducted a multicenter retrospective study in nine referral centers and included patients with psoriasis who had received secukinumab between March 2018 to November 2020. Data on demographic characteristics, Psoriasis Area and Severity Index (PASI) scores, and previous treatments were collected from medical records. Patients were evaluated at 12, 24, and 52 weeks with respect to response to treatment and side effects. Results: In total, 229 patients were recruited for the study. A PASI score improvement of ≥90 points over the baseline was achieved by 79%, 69.8%, and 49.3% of patients at weeks 12, 24, and 52, respectively. The most common adverse events wereCandida infections and fatigue. In total, 74 (32%) patients discontinued treatment by week 52, including due to adverse events, or secondary ineffectiveness. Study limitations: Retrospective design. Conclusions: These findings suggest that secukinumab therapy is reasonably effective in patients with moderate-to-severe psoriasis. Comorbidities and time length of the disease can affect the response to treatment. The rates of adverse events were high in this patient population.
  • Fibroblast morphology, growth rate and gene expression in facial melasma Original Article

    Espósito, Ana Cláudia Cavalcante; Brianezi, Gabrielli; Miot, Luciane Donida Bartoli; Miot, Hélio Amante

    Resumo em Inglês:

    Abstract Background: In addition to melanocytic hyperfunction, changes are observed in the upper dermis of melasma, and fibroblasts play a central role in collagen synthesis and pigmentation induction. Objective: To explore the morphology, growth rate, and gene expression profile of fibroblasts from the skin with melasma in comparison to fibroblasts from the adjacent healthy skin. Methods: Ten women with facial melasma were biopsied (lesion and adjacent healthy skin), and the fragments were processed for fibroblast culture. Samples from five participants were seeded to evaluate growth (days 2, 5 and 8) and senescence (SA-β-gal) curves. The samples from the other participants were submitted to real-time PCR to comparatively evaluation of the expression of 39 genes. Results: Cultured fibroblasts from melasma skin were morphologically less fusiform in appearance and on average a 34% (95% CI 4%–63%) greater proportion of cells labeled with SA-β-gal than the fibroblasts from the adjacent skin. The cell growth rate was lower for the melasma samples after eight days (p < 0.01). The WNT3A, EDN3, ESR2, PTG2, MMP1, and SOD2 genes were up-regulated, whereas the COL4A1, CSF2, DKK3, COL7A1, TIMP4, CCL2, and CDH11 genes were down-regulated in melasma skin fibroblasts when compared to the ones from adjacent healthy skin. Study limitations: Small sample size; absence of functional tests. Conclusions: Fibroblasts from the skin with melasma showed a lower growth rate, less fusiform morphology and greater accumulation of SA-β-gal than those from adjacent photo exposed skin. Moreover, their gene expression profile comprised factors that may contribute to upper dermis damage and sustained melanogenesis.
  • Intraoperative assessment of surgical margins using ‟en face” frozen sections in the management of cutaneous carcinomas Original Article

    Otsuka, Ana Carolina Vasconcellos Guedes; Bertolli, Eduardo; Macedo, Mariana Petaccia de; Pinto, Clovis Antonio Lopes; Duprat Neto, João Pedreira

    Resumo em Inglês:

    Abstract Background: Basal cell and squamous cell carcinomas (BCC and SCC) are the most common types of cancer worldwide. Intraoperative assessment of surgical margins by frozen section has been widely used to ensure disease-free margins. The intraoperative ‟en face” freezing technique evaluates all peripheral and deep margins. Objective: To report the results of the ‟en face” freezing technique in relation to tumor recurrence and agreement with paraffin-embedded tissue examination. Methods: Retrospective analysis of patients undergoing surgical excision of BCC and SCC at the A. C. Camargo Cancer Center, Brazil. Results: This study included 542 skin carcinomas, which were excised from 397 patients. A total of 201 male patients (50.6%), and 196 female patients (49.4%) were assessed, whose mean age was 64 years. The tumors were mostly located on the head and neck region (87.8%). BCC corresponded to 79.7% of the cases. The mean follow-up was 38 months. Tumor relapse occurred in 0.86% of the primary tumors and 3.7% of recurrent tumors. The result of the intraoperative ‟en face” frozen section evaluation was in agreement with the final result of the anatomopathological examination (paraffin test) in 98% of the lesions. Study limitations: Not having a minimum follow-up time of 5 years for all patients. Conclusion: The ‟en face” freezing technique shows low tumor relapse, being reliable and safe to guarantee negative surgical margins of the tumor.
  • Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes? Original Article

    Kocatürk, Emek; Başkan, Emel Bülbül; Küçük, Özlem Su; Özdemir, Mustafa; Örnek, Sinem; Can, Pelin Kuteyla; Hașal, Eda; Engin, Burhan; Atakan, Nilgün; Alpsoy, Erkan

    Resumo em Inglês:

    Abstract Background: Chronic Spontaneous Urticaria (CSU) is characterized by recurrent wheals and/or angioedema for longer than 6-weeks. Guidelines recommend Omalizumab (Oma) as first-line and Cyclosporine-A (Cs-A) as second-line treatment in antihistamine resistant CSU. This step-wise algorithm might be time-consuming and costly. Objective: To determine indicators of response to Oma or Cs-A in CSU patients. Methods: We retrospectively analyzed data from seven centers in Turkey; the inclusion criteria for patients were to receive both Oma and Cs-A treatment (not concurrently) at some point in time during their follow-up. Clinical and laboratory features were compared between groups. Results: Among 110 CSU patients; 47 (42.7%) were Oma-responders, 15 (13.6%) were Cs-A-responders, and 24 (21.8%) were both Oma and Cs-A responders and 24 (21.8%) were non-responders to either drug. High CRP levels were more frequent in Cs-A-responders (72.7% vs. 40.3%; p = 0.055). Oma-responders had higher baseline UCT (Urticaria Control Test) scores (6 vs. 4.5; p = 0.045). Responders to both drugs had less angioedema and higher baseline UCT scores compared to other groups (33.3% vs. 62.8%; p = 0.01 and 8 vs. 5; p = 0.017). Non-responders to both drugs had an increased frequency in the female gender and lower baseline UCT scores compared to other groups (87.5% vs. 61.6%; p = 0.017 and 5 vs. 7; p = 0.06). Study Limitations: Retrospective nature, limited number of patients, no control group, the lack of the basophil activation (BAT) or BHRA (basophil histamine release assay) tests. Conclusions: Baseline disease activity assessment, which considers the presence of angioedema and disease activity scores, gender, and CRP levels might be helpful to predict treatment outcomes in CSU patients and to choose the right treatment for each patient. Categorizing patients into particular endotypes could provide treatment optimization and increase treatment success. © 2022 Published by Elsevier España, S.L.U. on behalf of Sociedade Brasileira de Dermatologia. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).
  • Predictive factors of melanoma thickness Original Article

    Silva, Ana Rita Carreiro; Vieira, Ricardo José David Costa

    Resumo em Inglês:

    Abstract Background: Melanoma thickness is a relevant prognostic marker that is crucial for staging and its calculation relies on the histopathological examination. There is a risk of thickness underestimation with an incisional biopsy if the latter is not performed on a tumor area where the thickness is maximal. This occurrence may have an impact on a therapeutic decision, particularly regarding the excision margins and the need for sentinel lymph node biopsy. Objective: To assess the association between melanoma thickness and dermoscopic, demographic, epidemiological and clinical variables, aiming to identify predictive factors of thickness >1 mm. Methods: This was an observational and cross-sectional study, carried out on patients diagnosed with melanoma, from a single center over a time span of four years. Anatomopathological (thickness), dermoscopic, demographic, epidemiological, and clinical variables were collected. The associations between the variables with melanoma thickness were assessed. Results: A total of 119 patients were included. The presence of atypical vessels on the dermoscopic examination was an independent predictive factor of thickness >1 mm. Conversely, an atypical reticular pattern predicted melanoma thickness <1 mm. The presence of ephelides and a previous history of sunburn were also associated with melanomas thinner than 1 mm in the univariate analysis. Study limitations: The lack of data related to some variables and the absence of an optimal correlation between the dermoscopic and the anatomopathological examination constituted study limitations. Conclusion: An atypical vascular pattern on dermoscopy is associated with thickness >1 mm, helping with the choice of the optimal site to perform an incisional biopsy when an excisional biopsy is not feasible.
  • The relationship between erythema nodosum and prognosis in systemic sarcoidosis: a retrospective cohort study Original Article

    Yıldırım, Elif Afacan; Öztürk, Perihan Aladaǧ; Adıșen, Esra; Köktürk, Nurdan

    Resumo em Inglês:

    Abstract Background: Erythema Nodosum (EN) is the most common skin manifestation in sarcoidosis and has often been associated with a good prognosis. Objectives: To compare the clinical characteristics and treatment-related features in patients with sarcoidosis according to whether or not EN was seen as a presenting symptom at the time of diagnosis. Methods: A 20-year single-center retrospective study was performed. The following two groups were identified: one group with EN as one of the presenting symptoms at the time of diagnosis of sarcoidosis (EN group) and a second group without EN as a presenting symptom at diagnosis (non-EN group). The clinical characteristics and treatment modalities were collected from the medical records. Results: A total of 122 patients (31 in the EN group, 91 in the non-EN group) were included. Radiological stages of pulmonary disease were significantly lower in the EN group. Articular involvement was more common in the EN group (p = 0.001), whereas other systemic organ involvements (p = 0.025), especially neurological involvement (p = 0.036), were significantly more common in the non-EN group. In the EN group, a higher percentage of patients were managed without systemic therapy (71.0% vs. 54.9%) and spontaneous remission was more frequent (25.0% vs. 14.1%), however, this wasn’t statistically significant. Study limitations: Retrospective design. Conclusions: The lower radiological stage of pulmonary sarcoidosis and lower frequency of systemic organ involvement in patients with EN augment the prognostic value of EN highlighted in the literature. However, this study couldn’t confirm that the patients with EN would need less systemic therapy in the course of their disease.
  • The risk of organ-based comorbidities in psoriasis: a systematic review and meta-analysis Original Article

    Tang, Xuemei; Chen, Ling

    Resumo em Inglês:

    Abstract Background: The close relationship between psoriasis and concomitant diseases is widely accepted. However, a comprehensive analysis of organ-based comorbidities in psoriasis is still lacking. Objective: The authors aimed to present the risk of organ-based comorbidities in psoriasis by comparing the general population. Methods: The authors retrieved a search of Pubmed, EMBASE, and Cochrane databases for studies reporting organ-based comorbidities in psoriasis versus the general population. Observational studies that met the following criteria were assessed: 1) Psoriasis diagnosis; 2) Cardiovascular or kidney or liver or respiratory or cerebrovascular outcomes; 3) Comparison group of individuals without psoriasis. Pooled Relative Risks (pRRs) and 95% Confidence Intervals (CIs) were calculated by using the random-effect model. Results: Fifteen observational studies with 216,348 psoriatic patients and 9,896,962 individuals from the general population were included. Psoriasis showed a greater risk of organ-based comorbidities. Compared to the general population, pRR for all organ-based comorbidities was 1.20 (95% CI 1.11–1.31) in psoriasis, and pRR was lower in mild 0.61 (95% CI 0.46–0.81) than in moderate/severe patients. pRR was 1.20 (95% CI 1.11–1.30) for cardiovascular, 1.56 (95% CI 1.20–2.04), and 1.75 (95% CI 1.33–2.29) for cerebrovascular and liver diseases, respectively. pRR for coexisting renal and cardiovascular events was 1.09 (95% CI 1.01–1.18). pRR for coexisting renal and cerebrovascular events was 1.28 (95% CI 0.99–1.66). pRR for coexisting renal and liver diseases was 1.46 (95% CI 1.10–1.94). pRR for coexisting cardiovascular and liver diseases was 1.41 (95% CI 1.11–1.80). Study limitations: There is heterogeneity. Conclusion: Psoriasis has a higher risk of single and multiple organ-based comorbidities than the general population. The present study will further improve attention to psoriasis as a systemic inflammatory disease.
  • Pigmented eccrine poroma in an atypical location Dermatopathology

    Alfredo, Melissa de Almeida Corrêa; Lai, Mariana Righetto de Ré; Miot, Luciane Donida Bartoli; Haddad, Gabriela Roncada; Garcia, Aline Lutz; Miot, Hélio Amante

    Resumo em Inglês:

    Abstract Eccrine poroma is the term that includes benign neoplasms of the terminal duct of the eccrine sweat glands, which may clinically and dermoscopically resemble other melanoma and non-melanoma skin tumors. They are often located on the extremities (especially palms and soles), presenting as normochromic or erythematous papules and nodules, measuring up to 2 cm. Pigmented variants are uncommon, accounting for less than 20% of cases. This report describes a 37-year-old man who developed a large pigmented eccrine poroma on his right shoulder, causing diagnostic difficulty. Histopathological examination revealed a nodular neoplasm consisting of small, monomorphic, cuboidal cells, with ample, eosinophilic cytoplasm and well-defined borders, in addition to conspicuous intercellular bridges, with melanin deposits diffusely distributed inside them. The absence of cytological atypia, cellular pleomorphism, increased mitotic activity, and necrosis foci corroborated the diagnostic exclusion of porocarcinoma, which can develop from eccrine poroma.
  • Sebaceous nevus of Jadassohn: review and clinical-surgical approach Review

    Silva Neto, Manoel Pereira da; Assis, Barbara Rodovalho de; Andrade, Gustavo Rodrigues

    Resumo em Inglês:

    Abstract Background: Nevus sebaceous of Jadassohn is defined as a rare congenital malformation characterized as a non-hereditary hamartoma of the adnexal structures of the skin. Its etiology is not yet well understood, but it is believed to be related to post-zygotic mutations in the HRAS, NRAS and KRAS genes. Objective: To describe the clinical manifestation of nevus sebaceous, as well as the main management techniques addressed in the medical literature. Moreover, the present study discusses a case report of a congenital linear nevus in the left retroauricular region found in a male patient, without extracutaneous manifestations. Method: A narrative review of the literature was carried out. Discussion: Nevus sebaceous occurs as lesions with a linear or oval appearance, with a smooth or verrucous texture, generally alopecic and with very variable color. Moreover, nevus sebaceous is one of the components of the so-called linear nevus syndrome or Schimmelpenning-Feuerstein-Mims syndrome, which is associated with multisystemic complications. The treatment of the lesions is still controversial; however, most experts indicate surgical excision as the most frequently adopted treatment method, in addition to multidisciplinary follow-up when the diagnosis of Schimmelpenning-Feuerstein-Mims syndrome is established. Conclusion: The linear nevus syndrome constitutes a rare manifestation; however, its diagnosis should be considered in children born with nevus sebaceous. There is no consensus yet on the best therapy, but surgical removal has shown to be a viable option.
  • Kerion celsi caused by Trichophyton tonsurans in an adult Tropical/infectoparasitary Dermatology

    Sotelo, Jacqueline Paulina Aguirre; Martinez, Víctor Manuel Tarango; Cabrera, Lucio Vera

    Resumo em Inglês:

    Abstract Tinea capitis is an uncommon infection in adults, and predominantly affects women and the elderly with hormonal disorders and immunosuppression. Clinical features are often polymorphic and atypical. A kerion celsi case in an elderly female patient with type 2 diabetes mellitus and menopause is presented. The diagnosis was established by direct examination and the isolation of Trichophyton tonsurans in culture and typified by microculture. Treatment with prednisone and itraconazol was very successful. Recognizing the presentation of tinea capitis in adults will help clinicians to avoid delay in the diagnosis, awareness of the risk factors and provide early treatment to minimize sequelae of the disease.
  • Malignant syphilis in a patient with acquired human immunodeficiency virus (HIV) infection Tropical/infectoparasitary Dermatology

    Pereira, Ana Sofia; Lozada, Aluixa; Monteiro, Ana Filipe

    Resumo em Inglês:

    Abstract Malignant syphilis is an uncommon variant of syphilis, most often (but not always) found in immunosuppressed individuals. This report describes the case of a 57-year-old man, infected with the acquired human immunodeficiency virus (HIV), with a generalized picture of erythematous-squamous papules that rapidly progressed to painful and ulcerated plaques and nodules, some covered with a black rupioid crust. The analytical study performed revealed positive VDRL (Venereal Disease Research Laboratory) and RPR (Rapid Plasma Reagin). The skin biopsy was nonspecific; however, the immunohistochemical analysis disclosed the presence of spirochetes. The patient was then treated with benzathine penicillin G 2.4 MU once a week IM for three weeks, with progressive resolution of the lesions. Considering its rarity, this atypical form of syphilis that needs to be known to better recognize its clinical presentation and provide more prompt treatment to patients.
  • Darier disease: the use of dermoscopy in monitoring acitretin treatment Images In Dermatology

    Silva-Hirschberg, Catalina; Cabrera, Raúl; Rollán, María Paz; Castro, Alex

    Resumo em Inglês:

    Abstract Darier disease is an uncommon autosomal dominant inherited disease, caused by a mutation in the ATP2A2 gene. The clinical findings are hyperkeratotic papules on the trunk, scalp, face, and neck, maceration of intertriginous areas, palmar pits, whitish papules on the oral mucosa and nail abnormalities. The main histopathologic findings are acantholysis and dyskeratotic keratinocytes. Dermatoscopic features are comedo-like openings with a central polygonal yellowish/brownish structure, surrounded by a whitish halo. First-line treatment includes acitretin. Five reports have been published describing Darier disease dermatoscopic findings. Herein, we report for the first time a patient under acitretin treatment and dermatoscopic follow-up.
  • Photosensitive rash induced by nivolumab Images In Dermatology

    Navarro-Triviño, Francisco J.; Ruiz-Villaverde, Ricardo

    Resumo em Inglês:

    Abstract The therapeutic approach to metastatic melanoma has revolutionized the clinical course of this disease. Since 2011, different immunotherapeutic drugs have been approved. Nivolumab is a humanized immunoglobulin IgG4 monoclonal antibody that binds to the PD-1 receptor, blocking its interaction with his ligand PD-L1. The authors present a new case of photosensitivity induced by nivolumab. The photo exposed distribution of the eruption, the sun exposure prior to the beginning of the eruption, and the chronological relationship with the beginning of the treatment are data that have allowed us to confirm the suspected clinical diagnosis.
  • Case for diagnosis. Stewart-Treves syndrome after mastectomy What Is Your Diagnosis?

    Sato, Roberta Akeme de Oliveira; Pinto, Clovis Antônio Lopes; Alves, Celia Antonia Xavier de Moraes; Ferreira, Juliana Arêas de Souza Lima Beltrame
  • Alopecia areata: descriptive analysis in a Brazilian sample Research Letter

    Lopes, Andressa Sato de Aquino; Santos, Leopoldo Duailibe Nogueira; Razé, Mariana de Campos; Lazzarini, Rosana
  • Application of the Brazilian patch test panel in the diagnosis of allergic contact dermatitis to cosmetics Research Letter

    Villarinho, Ana Luiza Castro Fernandes; Melo, Maria das Graças Mota; Teixeira, Liliane Reis
  • Dermoscopic characteristics of congenital melanocytic nevi in a cohort study in southern Brazil Research Letter

    Rocha, Camila Roos Mariano da; Grazziotin, Thais Corsetti; Bonamigo, Renan Rangel
  • Dermoscopy and ultrasonography of Kaposi’s sarcoma nodules: new insights to guide intralesional chemotherapy? Research Letter

    Nazzaro, Gianluca; Tourlaki, Athanasia; Maronese, Carlo Alberto; Zelin, Enrico; Passoni, Emanuela; Brambilla, Lucia
  • Dermoscopy in synchronous melanomas: a case series Research Letter

    Sá, Daniel Coelho de; Pinheiro, Juliana Abreu; Magalhães, Emmanuel Pereira Benevides; Pontes, Maria Araci de Andrade
  • Frequency of complications after dermatological surgeries in the elderly Research Letter

    Almeida, Isabella Parente; Saraiva, Maria Isabel Ramos; Messina, Maria Cristina de Lorenzo; Castro, Luiz Guilherme Martins
  • Melkersson-Rosenthal syndrome in children and adolescents: a series of seven cases Research Letter

    Gavioli, Camila Fátima Biancardi; Cidade, Yasmin da Silva Amorim; Florezi, Giovanna Piacenza; Lourenço, Silvia Vanessa; Nico, Marcello Menta Simonsen
  • Acute genital ulcers in a young girl: a clinical challenge: Lipschütz ulcer Case Letter

    Schafer, Fabiola; Miranda, Rodrigo
  • An unusual presentation of cutaneous pseudolymphoma Case Letter

    Wang, Ying; Li, Sitong; Bai, Yanping; Zheng, Zhancai
  • Cutaneous tuberculosis chancre: case description in a child Case Letter

    Haddad, Gabriela Roncada; Florêncio, Lívia Caramaschi; Haddad Junior, Vidal
  • Eruptive collagenoma in a juvenile patient with Down syndrome Case Letter

    Kato, Yasunobu; Yamamoto, Toshiyuki
  • Multiple painless papulonodules in a 3-year-old girl: type A lymphomatoid papulosis Case Letter

    Gomes, Nuno; Nogueira, Ana; Silva, Roberto; Azevedo, Filomena
  • Papular acantholytic dyskeratosis of the perianal region in a young woman Case Letter

    Ramirez, Laura Trujillo; Cardona, Camilo Andres Morales; Takegami, Juan Carlos Hiromi Lopez
  • Pemphigus vulgaris with exclusive manifestation in one of monozygotic twins: could environmental factors be involved? Case Letter

    Farid, Marcela Rosa de Almeida; Bueno-Filho, Roberto; Donadi, Eduardo Antônio; Roselino, Ana Maria
  • Phototoxic drug eruption induced by vandetanib used for the treatment of metastatic medullary thyroid cancer Case Letter

    Bostan, Ecem; Gulseren, Duygu; Gokoz, Ozay
Sociedade Brasileira de Dermatologia Av. Rio Branco, 39 18. and., 20090-003 Rio de Janeiro RJ, Tel./Fax: +55 21 2253-6747 - Rio de Janeiro - RJ - Brazil
E-mail: revista@sbd.org.br